Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient

Muscle and Nerve

Volumn 36, Issue 1, 2007, Pages 115-117

  Sha, Sharon J ^a   Layzer, Robert B ^b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylcholine receptor antibodies; Lambert Eaton myasthenic syndrome; Myasthenia gravis; Thymic hyperplasia

Indexed keywords

3,4 DIAMINOPYRIDINE; CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; PYRIDOSTIGMINE;

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; DRUG DOSE INCREASE; EATON LAMBERT SYNDROME; ELECTRODIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMECTOMY; THYMUS HYPERPLASIA;

4-AMINOPYRIDINE; ADOLESCENT; CHOLINESTERASE INHIBITORS; ELECTRODIAGNOSIS; FEMALE; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; MYASTHENIA GRAVIS; POTASSIUM CHANNEL BLOCKERS; PYRIDOSTIGMINE BROMIDE; THYMECTOMY;

EID: 34347352103     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20735     Document Type: Article

References (27)

1. Burns TM, Russell JA, LaChance DH, Jones HR. Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome. Ann Neurol 2003;53:270-273.
2. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330: 1797-1810.
3. Eymard B, Berrih-Aknin S. Role of the thymus in the physiopathology of myasthenia. Rev Neurol (Paris) 1995;151:6-15.
4. Garlepp MJ, Kay PH, Dawkins RL. The diagnostic significance of autoantibodies to the acetylcholine receptor. J Neuroimmunol 1982;3:337-350.
5. Hoch W, McConville J, Helms S, Newsom-Davis J, Melius A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-368.
6. Ihara Y, Kuroda S, Otsuki S. A case of malignant thymoma associated with Eaton-Lambert-type neuromuscular transmission block and sensorimotor neuropathy. Rinsho Shinkeigaku 1990;30:750-753.
7. Katz JS, Wolfe GI, Bryan WW, Tintner R, Barohn RJ. Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome. Neurology 1998;50:47-475.
8. Lambert EH, Rooke ED. Myasthenic state and lung cancer. In: Brain RW, Norris FH, editors. The remote effects of cancer on the nervous system. New York: Grune & Stratton; 1965. p 67-80.
9. Lambert EH, Rooke ED, Eaton LM, Hodgson CH. Myasthenic syndrome occasionally associated with bronchial neoplasm: neurophysiologic studies. In: Viets HR, editor. Myasthenia gravis. Springfield, IL: Thomas; 1961. p 362-410.
10. Lauritzen M, Smith T, Fischer-Hansen B, Sparup J, Olesen J. Eaton-Lambert syndrome and malignant thymoma. Neurology 1980;30:643-648.
11. Mareska M, Gutmann L. Lambert-Eaton myasthenic syndrome. Semin Neurol 2004;24:149-153.
12. Martin-Moutot N, Haro L, Santos RG, Mori Y, Seagar M. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome. Neurobiol Dis 2006;22:57-63.
13. Mayer RE, Williams, IR. Incrementing responses in myasthenia gravis. Arch Neurol 1974;31:24-26.
14. Motomura M, Iwanaga H. Lambert-Eaton myasthenic syndrome: diagnosis and treatment. Clin Calcium 2001;11:1468-1474.
15. Newsom-Davis J, Leys K, Vincent A, Ferguson I, Modi G, Mills K. Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients. J Neurol Neurosurg Psychiatry 1991;54:452-453.
16. Oh SJ, Dwyer DS, Bradley RJ. Overlap myasthenic syndrome: combined myasthenia gravis and Eaton-Lambert syndrome. Neurology 1987;37:1411-1414.
17. Oh SJ, Kim DE, Kuruoglu R, et al. Diagnostic sensitivity of the laboratory tests in myasthenia gravis. Muscle Nerve 1992;15: 720-724.
18. Oh SJ, Sher E. MG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence. Clin Neurophysiol 2005;116:1167-1171.
19. O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988;111: 577-596.
20. Ozdemir C, Young, RR. Electrical testing in myasthenia gravis. Ann NY Acad Sci 1971;183:287-302.
21. Sanders DB, El-Salem K, MasseyJM, McConville J, Vincent A. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003;60:1978-1980.
22. Shahrizaila N. Thymectomy in myasthenia gravis: comparison of outcome in Santiago, Cuba and Nottingham, UK. J Neurol 2005;252:1262-1266.
23. Tabbaa MA, Leshner RT, Campbell WW. Malignant thymoma with dysautonomia and disordered neuromuscular transmission. Arch Neurol 1986;43:955-957.
24. Verma PK, Oger JJ. Seronegative generalized myasthenia gravis: low frequency of thymic pathology. Neurology 1992;42: 586-589.
25. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985;48:1246-1252.
26. Wirtz PW, Sotodeh M, Nijnuis M, Van Doom PA, Van Engelen BG, Hintzen RQ, et al. Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 2002;73:766-768.
27. Yin HL, Zhang TH, Zhou ZS. Clinical pathological study of resected thymus from 104 myasthenia gravis patients. Zhonghua Bing Li Xue Za Zhi 1994;23:89-92.